Detecting lymph node metastasis using artificial intelligence

Determining lymph node involvement for breast cancer patients constitutes an integral part of the treatment decision. The lymph node assessment is usually performed by an expert pathologist using one or multiple hematoxylin and eosin (H&E) stained tissue sections per lymph node. Given that several lymph nodes are accessed per patient, the workload quickly increases for the pathologist.

Understanding these drawbacks, Visiopharm has developed an AI application for automatic lymph node metastasis detection in breast cancer. The algorithm detects micro and macro metastasis with high accuracy and presents the pathologist with visual results for review.

In this webinar, you will learn how precisely the AI algorithm detects micro and macro metastases and learn how Visiopharm’s software can be used to triage slides for a faster review.

This webinar was presented live on Thursday, October 24, 2019.